Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05310786 · ClinicalTrials.gov registry record · NA
Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder
A NA study, sponsored by Trustees of Dartmouth College.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
NCT05310786: Completed NA study, sponsored by Trustees of Dartmouth College.
NCT05310786 is a NA study that has completed, run by Trustees of Dartmouth College. The registered enrollment target is 149 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05310786, a NA study, has completed, sponsored by Trustees of Dartmouth College.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
Study Summary
This project will provide novel empirical information about how to optimally engage pharmacists and pharmacies as key partners in collaborative integrated care models designed to expand access to evidence-based medication treatment for OUD which may inform a larger experimental design that seeks to evaluate best ways to scale-up this model across the nation. This Phase 1 project seeks to evaluate the feasibility, acceptability, and impact of implementing a pharmacist-integrated model of MOUD into approximately four diverse outpatient clinical sites.
Primary Outcome
The SIC is a date-driven measure of implementation milestones spanning activities from the Pre-implementation through Competency stages of implementation.
Interventions
- OTHER Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2022-08-18 |
| Est. Completion | 2025-02-05 |
| Phase | NA |
What the finished NCT05310786 record still lists
NCT05310786 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO) is the first listed.
NCT05310786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05310786 about?
NCT05310786 is a clinical study titled "Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder". This project will provide novel empirical information about how to optimally engage pharmacists and pharmacies as key partners in collaborative integrated care models designed to expand access to evidence-based medication treatment for OUD which may inform a larger experimental design that seeks to ...
What is the current status of trial NCT05310786?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2022-08-18. Estimated completion is 2025-02-05.
What interventions are being tested in trial NCT05310786?
The interventions under investigation include: Pharmacist-integrated Medication Treatment for Opioid Use Disorder (PrIMO) (OTHER).
Who is sponsoring clinical trial NCT05310786?
This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05310786's enrollment target sits among peer trials
149 702nd of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI